Канал: The Innovative Health Initiative

IHI Brokerage Event - 13 November 2024

IHI Brokerage Event - 13 November 2024

IHI Brokerage Event - 12 November 2024

IHI Brokerage Event - 12 November 2024

Info session - Preparing for IHI call 9

Info session - Preparing for IHI call 9

IMI impact on mental health disorders

IMI impact on mental health disorders

Masterclass – how to unlock the potential of data sharing in collaborative projects

Masterclass – how to unlock the potential of data sharing in collaborative projects

IHI Call 8 Topic 3 Modelling regulatory sandbox mechanisms and enabling their deployment to suppor

IHI Call 8 Topic 3 Modelling regulatory sandbox mechanisms and enabling their deployment to suppor

IHI Call 8 Topic 4 Patient centred clinical study endpoints derived using digital health technolog

IHI Call 8 Topic 4 Patient centred clinical study endpoints derived using digital health technolog

IHI Call Days - call 8 - June 2024 - Big data and osteoarthritis

IHI Call Days - call 8 - June 2024 - Big data and osteoarthritis

IHI Call Days - call 8 - June 2024 - Tackling cardiovascular disease in cities

IHI Call Days - call 8 - June 2024 - Tackling cardiovascular disease in cities

IHI Call Days - call 8 - June 2024 - Rules & procedures for two-stage calls.

IHI Call Days - call 8 - June 2024 - Rules & procedures for two-stage calls.

In conversation with... RTCure

In conversation with... RTCure

IMI impact on antimicrobial resistance

IMI impact on antimicrobial resistance

In conversation with... EBiSC2

In conversation with... EBiSC2

IHI at DIA Europe 2024

IHI at DIA Europe 2024

IKOP reporting for IHI private members and contributing partners (March 2024)

IKOP reporting for IHI private members and contributing partners (March 2024)

Pitching session Call 7, topic 3 - Clinical validation of biomarkers (2/2)

Pitching session Call 7, topic 3 - Clinical validation of biomarkers (2/2)

Pitching session Call 7, topic 3 - Clinical validation of biomarkers (1/2)

Pitching session Call 7, topic 3 - Clinical validation of biomarkers (1/2)

Pitching session Call 7, topic 2: Optimised hospital workflows.

Pitching session Call 7, topic 2: Optimised hospital workflows.

Pitching session Call 7, topic 1: Management of heart disease (2/2)

Pitching session Call 7, topic 1: Management of heart disease (2/2)

Pitching session Call 7, topic 1: Management of heart disease (1/2)

Pitching session Call 7, topic 1: Management of heart disease (1/2)

IHI Call Days - call 6 - January 2024 - Treatment persistency.

IHI Call Days - call 6 - January 2024 - Treatment persistency.

IHI Call Days - call 6 - January 2024 - RWD/RWE in decision-making.

IHI Call Days - call 6 - January 2024 - RWD/RWE in decision-making.

IHI Call Days - call 6 - January 2024 - Rules & procedures: two-stage calls.

IHI Call Days - call 6 - January 2024 - Rules & procedures: two-stage calls.

IHI Call Days - call 7 - January 2024 - Single stage calls: financial aspects.

IHI Call Days - call 7 - January 2024 - Single stage calls: financial aspects.

IHI Call Days - call 7 - January 2024 - Rules & procedures for single-stage calls.

IHI Call Days - call 7 - January 2024 - Rules & procedures for single-stage calls.

IHI Call Days - call 7 - January 2024 - Clinical validation of biomarkers.

IHI Call Days - call 7 - January 2024 - Clinical validation of biomarkers.

IHI Call Days - call 7 - January 2024 - Management of heart disease.

IHI Call Days - call 7 - January 2024 - Management of heart disease.

IHI Call Days - call 7 - January 2024 - Optimised hospital workflows.

IHI Call Days - call 7 - January 2024 - Optimised hospital workflows.

Joint IHI - EIT Health workshop - Bridging the gap - 21 Nov 2023

Joint IHI - EIT Health workshop - Bridging the gap - 21 Nov 2023

IMI impact on: Vaccines - 10 November 2023

IMI impact on: Vaccines - 10 November 2023

IHI contributing partners: who, why and how - 12 October 2023

IHI contributing partners: who, why and how - 12 October 2023

IMI vs Ebola

IMI vs Ebola

Pitching session - Call 5 topic 2 - Enabling broader access to theranostics solution in Europe.

Pitching session - Call 5 topic 2 - Enabling broader access to theranostics solution in Europe.

IMI is revolutionising clinical trials

IMI is revolutionising clinical trials

IHI Call Days - Call 5 - Preparing the financial part of the proposal

IHI Call Days - Call 5 - Preparing the financial part of the proposal

IHI Call Days - call 5 - June 2023 - Synthetic data generation.

IHI Call Days - call 5 - June 2023 - Synthetic data generation.

IHI Call Days - call 5 - June 2023 - Stroke management

IHI Call Days - call 5 - June 2023 - Stroke management

IHI Call Days - call 5 - June 2023 - Non-animal approaches for health technologies.

IHI Call Days - call 5 - June 2023 - Non-animal approaches for health technologies.

IHI Call Days - call 5- June 2023 - Theranostics solutions

IHI Call Days - call 5- June 2023 - Theranostics solutions

IHI Call Days - Info session - Call 5 - Rules and procedures - June 2023

IHI Call Days - Info session - Call 5 - Rules and procedures - June 2023

IHI Call Days - call 4 - June 2023 - Sustainable circular development and manufacture.

IHI Call Days - call 4 - June 2023 - Sustainable circular development and manufacture.

IHI Call Days - call 4 - June 2023 - SSbD packaging and devices

IHI Call Days - call 4 - June 2023 - SSbD packaging and devices

IHI Call Days - call 4 - June 2023 Improving trials for rare diseases.

IHI Call Days - call 4 - June 2023 Improving trials for rare diseases.

IHI Call Days - call 4 - June 2023 - Inclusive clinical studies

IHI Call Days - call 4 - June 2023 - Inclusive clinical studies

IHI Call Days - call 4 - June 2023 - Patient-centric blood sample collection

IHI Call Days - call 4 - June 2023 - Patient-centric blood sample collection

IHI Call Days - Call 4 - Info Session June 2023 - Expanding translational knowledge in minipigs

IHI Call Days - Call 4 - Info Session June 2023 - Expanding translational knowledge in minipigs

IHI Call Days - Info session - Call 4 - Rules and procedures - June 2023

IHI Call Days - Info session - Call 4 - Rules and procedures - June 2023

IMI impact on: Ebola - 13 June 2023

IMI impact on: Ebola - 13 June 2023

IMI impact on: Clinical trials - 25 May 2023

IMI impact on: Clinical trials - 25 May 2023

IHI Patient Pool Webinar - 11 May 2023

IHI Patient Pool Webinar - 11 May 2023

IMI impact on: early career researchers

IMI impact on: early career researchers

Project Spotlight: PharmaLedger - 28 Feb 2023

Project Spotlight: PharmaLedger - 28 Feb 2023

IHI Call Days - Call 4 - Info Session - Expanding translational knowledge in minipigs

IHI Call Days - Call 4 - Info Session - Expanding translational knowledge in minipigs

IHI Call Days - Call 4 - Info Session - Patient-centric blood sample collection

IHI Call Days - Call 4 - Info Session - Patient-centric blood sample collection

IHI Call Days - Call 3 - Pitching Session - Improving outcomes in hospitals

IHI Call Days - Call 3 - Pitching Session - Improving outcomes in hospitals

IHI Call Days - Call 3 - Info Session - Improving outcomes in hospitals

IHI Call Days - Call 3 - Info Session - Improving outcomes in hospitals

IHI Call Days - Call 3 - Pitching Session - Screening platform & biomarkers

IHI Call Days - Call 3 - Pitching Session - Screening platform & biomarkers

IHI Call Days - Call 3 - Pitching Session - Patient-generated evidence for better outcomes

IHI Call Days - Call 3 - Pitching Session - Patient-generated evidence for better outcomes

IHI Call Days - Call 3 - Info Session - Patient-generated evidence for better outcomes

IHI Call Days - Call 3 - Info Session - Patient-generated evidence for better outcomes

IHI Call Days - Call 3 - Info Session - Screening platform & biomarkers

IHI Call Days - Call 3 - Info Session - Screening platform & biomarkers

IHI Call Days - Call 3 - Preparing the financial part of the proposal

IHI Call Days - Call 3 - Preparing the financial part of the proposal

IHI Call Days - Call 3 - Pitching Session - Advanced therapies for rare diseases

IHI Call Days - Call 3 - Pitching Session - Advanced therapies for rare diseases

IHI Call Days - Call 3 - Info Session - Advanced therapies for rare diseases

IHI Call Days - Call 3 - Info Session - Advanced therapies for rare diseases

IHI Call Days - Call 3 - Info Session - Digital Technologies and mental health

IHI Call Days - Call 3 - Info Session - Digital Technologies and mental health

IHI Call Days - Call 3 - Pitching Session - Digital technologies and mental health

IHI Call Days - Call 3 - Pitching Session - Digital technologies and mental health

IHI Call Days - Call 3 - Single Stage calls Rules and Procedures

IHI Call Days - Call 3 - Single Stage calls Rules and Procedures

IHI's 1st birthday

IHI's 1st birthday

IMI Impact on Patient Involvement- Q&A

IMI Impact on Patient Involvement- Q&A

IMI Impact on Patient Involvement- Gary Hooker

IMI Impact on Patient Involvement- Gary Hooker

IMI Impact on Patient Involvement- Chris Roberts and Jayne Goodrick

IMI Impact on Patient Involvement- Chris Roberts and Jayne Goodrick

IMI Impact on Patient Involvement- Jane Taylor

IMI Impact on Patient Involvement- Jane Taylor

IMI Impact on Patient involvement- Jan Geissler

IMI Impact on Patient involvement- Jan Geissler

IMI Impact on Patient Involvement- Introduction

IMI Impact on Patient Involvement- Introduction

IMI Impact on Patient Involvement- Ellen Vrieze-Hermans

IMI Impact on Patient Involvement- Ellen Vrieze-Hermans

IHI webinar on preparing the financial part of the proposal

IHI webinar on preparing the financial part of the proposal

IHI Call 1 webinar on the neurodegenerative topic

IHI Call 1 webinar on the neurodegenerative topic

IHI brokerage- Rules, procedures, and SMEs

IHI brokerage- Rules, procedures, and SMEs

IHI brokerage- Introduction and presentation of call topics

IHI brokerage- Introduction and presentation of call topics

IHI call 2 webinar on the Cardiovascular topic

IHI call 2 webinar on the Cardiovascular topic

IHI call webinar on the personalised oncology topic

IHI call webinar on the personalised oncology topic

IHI call 1 webinar on the health data topic

IHI call 1 webinar on the health data topic

IHI Pitching Session- Call 2- Two-stage calls

IHI Pitching Session- Call 2- Two-stage calls

IHI Pitching Session- Call 1 Personalised oncology

IHI Pitching Session- Call 1 Personalised oncology

IHI Pitching Session- Call 1 Next generation imaging-guided diagnosis topic

IHI Pitching Session- Call 1 Next generation imaging-guided diagnosis topic

IHI Pitching Session- Call 1- Neurodegenerative diseases topic

IHI Pitching Session- Call 1- Neurodegenerative diseases topic

IHI Pitching Session- Call 1- Heterogeneous health data topic

IHI Pitching Session- Call 1- Heterogeneous health data topic

IHI call 2 webinar on the early feasibility studies topic

IHI call 2 webinar on the early feasibility studies topic

IHI call 1 webinar on the imaging and cancer topic

IHI call 1 webinar on the imaging and cancer topic

IHI call webinar on IHI's rules and procedures

IHI call webinar on IHI's rules and procedures

IMI impact on SMEs in health data management & health IT sectors

IMI impact on SMEs in health data management & health IT sectors

Concluding remarks by Maria da Graça Carvalho- Session 3 IHI launch event

Concluding remarks by Maria da Graça Carvalho- Session 3 IHI launch event

Meet the partners!- Session 2 of the launch event

Meet the partners!- Session 2 of the launch event

Get involved with IHI!- Session 1 of the launch event

Get involved with IHI!- Session 1 of the launch event

Introducing IHI: Europe's new partnership for health

Introducing IHI: Europe's new partnership for health

Welcome to the IHI founding partners

Welcome to the IHI founding partners

COCIR's Annika Eberstein welcomes IHI

COCIR's Annika Eberstein welcomes IHI

DG Research's Jean-Eric Paquet welcomes IHI

DG Research's Jean-Eric Paquet welcomes IHI

EFPIA's Nathalie Moll welcomes IHI

EFPIA's Nathalie Moll welcomes IHI

EuropaBio's Claire Skentelbery welcomes IHI

EuropaBio's Claire Skentelbery welcomes IHI

MedTech Europe's Patrick Boisseau welcomes IHI

MedTech Europe's Patrick Boisseau welcomes IHI

Vaccines Europe's Sibilia Quilici welcomes IHI

Vaccines Europe's Sibilia Quilici welcomes IHI

IMI Impact on Paediatric Medicine

IMI Impact on Paediatric Medicine

“Masterclass” Scaling Innovations Emerging from Public-Private Partnerships

“Masterclass” Scaling Innovations Emerging from Public-Private Partnerships

IMI impact on dementia - 15 June 2021 - Luc Truyen

IMI impact on dementia - 15 June 2021 - Luc Truyen

IMI impact on dementia - 15 June 2021 - Helen Rochford-Brennan

IMI impact on dementia - 15 June 2021 - Helen Rochford-Brennan

IMI impact on dementia - 15 June 2021 - Carlos Diaz

IMI impact on dementia - 15 June 2021 - Carlos Diaz

IMI impact on dementia - 15 June 2021 - Rachel Steeg

IMI impact on dementia - 15 June 2021 - Rachel Steeg

IMI impact on dementia - 15 June 2021 - Gill Farrar

IMI impact on dementia - 15 June 2021 - Gill Farrar

IMI impact on dementia - 15 June 2021 - closing remarks - Olivier Blin

IMI impact on dementia - 15 June 2021 - closing remarks - Olivier Blin

IMI impact on dementia - 15 June 2021 - Q&A

IMI impact on dementia - 15 June 2021 - Q&A

IMI impact on data - 9 June 2021 - Q&As

IMI impact on data - 9 June 2021 - Q&As

IMI impact on data - 9 June 2021 - Lars Bullinger

IMI impact on data - 9 June 2021 - Lars Bullinger

IMI impact on data - 9 June 2021 - Jennifer Lane

IMI impact on data - 9 June 2021 - Jennifer Lane

IMI impact on data - 9 June 2021 - Mats Sundgren

IMI impact on data - 9 June 2021 - Mats Sundgren

IMI impact on data - 9 June 2021 - Terttu Haring

IMI impact on data - 9 June 2021 - Terttu Haring

IMI Impact on diabetes - 8 June 2021 - Veerle Vanhuyse

IMI Impact on diabetes - 8 June 2021 - Veerle Vanhuyse

IMI impact on diabetes - 8 June 2021 - Ken Tait

IMI impact on diabetes - 8 June 2021 - Ken Tait

IMI impact on diabetes - 8 June 2021 - Chantal Mathieu

IMI impact on diabetes - 8 June 2021 - Chantal Mathieu

IMI impact on diabetes - 8 June 2021 - Maria Gomez

IMI impact on diabetes - 8 June 2021 - Maria Gomez

IMI impact on diabetes - 8 June 2021 - Emma Ahlqvist

IMI impact on diabetes - 8 June 2021 - Emma Ahlqvist

IMI impact on diabetes - 8 June 2021 - Closing Remarks - Eduard Montanya

IMI impact on diabetes - 8 June 2021 - Closing Remarks - Eduard Montanya

IMI impact on diabetes - 8 June 2021 - Questions and Answers

IMI impact on diabetes - 8 June 2021 - Questions and Answers

IMI-funded infrastructure: long term vision is vital

IMI-funded infrastructure: long term vision is vital

What's it like to take part in an INNODIA clinical trial?

What's it like to take part in an INNODIA clinical trial?

An unprecedented partnering machine

An unprecedented partnering machine

IMI's 13th birthday (30/04/2021)

IMI's 13th birthday (30/04/2021)

IMI is moving pain drug research forward.

IMI is moving pain drug research forward.

New vaccine technologies wouldn’t be possible without collaboration

New vaccine technologies wouldn’t be possible without collaboration

Driving rare diseases science forward

Driving rare diseases science forward

Webinar on the financial reporting of IMI2 in-kind contributions

Webinar on the financial reporting of IMI2 in-kind contributions

Stop protecting children from research

Stop protecting children from research

IMI Stakeholder Forum 2020 - Conclusion

IMI Stakeholder Forum 2020 - Conclusion

IMI Stakeholder Forum 2020 - Looking to the future of health research

IMI Stakeholder Forum 2020 - Looking to the future of health research

IMI Stakeholder Forum 2020-Integrating health research & innovation–paediatric cancer as a test case

IMI Stakeholder Forum 2020-Integrating health research & innovation–paediatric cancer as a test case

IMI Stakeholder Forum 2020 - Closing speech by Maria da Graça Carvalho (MEP)

IMI Stakeholder Forum 2020 - Closing speech by Maria da Graça Carvalho (MEP)

IMI Stakeholder Forum 2020 - Opening remarks by Pierre Meulien

IMI Stakeholder Forum 2020 - Opening remarks by Pierre Meulien

Our understanding of paediatric tumours is limited

Our understanding of paediatric tumours is limited

Regulators need solid evidence new tech is reliable. IMI projects can provide it.

Regulators need solid evidence new tech is reliable. IMI projects can provide it.

SMEs are the link between academia and industry

SMEs are the link between academia and industry

The fight against diabetes epidemic

The fight against diabetes epidemic

About COMBACTE-CARE

About COMBACTE-CARE

IMI is public, private, prepared

IMI is public, private, prepared

Launch of the last IMI2 Calls for proposals - Romanian

Launch of the last IMI2 Calls for proposals - Romanian

Launch of the last IMI2 Calls for proposals - Bulgarian

Launch of the last IMI2 Calls for proposals - Bulgarian

Launch of the last IMI2 Calls for proposals - Hungarian

Launch of the last IMI2 Calls for proposals - Hungarian

Launch of the last IMI2 Calls for proposals - Czech

Launch of the last IMI2 Calls for proposals - Czech

Launch of the last IMI2 Calls for proposals - Polish

Launch of the last IMI2 Calls for proposals - Polish

Launch of the last IMI2 Calls for proposals EN

Launch of the last IMI2 Calls for proposals EN

IMI: unravelling the enigmas of autoimmune disorders

IMI: unravelling the enigmas of autoimmune disorders

IMI COVID19 projects selected

IMI COVID19 projects selected

IMI making data FAIR

IMI making data FAIR

COVID 19 call

COVID 19 call

The promise of CAR T-cell therapy

The promise of CAR T-cell therapy

Cancer breakthroughs

Cancer breakthroughs

IMI2 - Call 20 launch - Polish

IMI2 - Call 20 launch - Polish

IMI2 - Call 20 launch - Bulgarian

IMI2 - Call 20 launch - Bulgarian

IMI2 - Call 20 launch - Romanian

IMI2 - Call 20 launch - Romanian

IMI2 - Call 20 launch - Hungarian

IMI2 - Call 20 launch - Hungarian

IMI2 - Call 20 launch - Czech

IMI2 - Call 20 launch - Czech

IMI2 - Call 20 launch EN

IMI2 - Call 20 launch EN

EHDEN study-a-thon

EHDEN study-a-thon

Patients involvement

Patients involvement

For us its all about the patients

For us its all about the patients

IMI2 - Call 20: updated draft topics (Dec. 2019)

IMI2 - Call 20: updated draft topics (Dec. 2019)

The inaccessible brain

The inaccessible brain

By the time Alzheimers symptoms begin to appear

By the time Alzheimers symptoms begin to appear

Interview with Isabelle Bekeredjian Ding on antimicrobial resistance

Interview with Isabelle Bekeredjian Ding on antimicrobial resistance

How are antibiotics like fire extinguishers?

How are antibiotics like fire extinguishers?

Bacteria or virus ? Value Dx

Bacteria or virus ? Value Dx

IMI at BIO-Europe 2019

IMI at BIO-Europe 2019

Getting the drug inside the bug - could antibiotics be disguised as nutrients?

Getting the drug inside the bug - could antibiotics be disguised as nutrients?

All diabetes patients are not the same - Interview with Ewan Pearson

All diabetes patients are not the same - Interview with Ewan Pearson

What will it be like when antibiotics stop working against everyday infections?

What will it be like when antibiotics stop working against everyday infections?

Twinning with African manufacturers - the VHFMoDRAD project

Twinning with African manufacturers - the VHFMoDRAD project

IMI2 - Call 20: draft topics

IMI2 - Call 20: draft topics

The world is getting closer to a licensed Ebola vaccine

The world is getting closer to a licensed Ebola vaccine

IMI's Ebola+ programme

IMI's Ebola+ programme

Ebola month intro 1080p

Ebola month intro 1080p

Jean Georges: What is patients' role in an IMI project?

Jean Georges: What is patients' role in an IMI project?

Tamás Letoha: What opportunities for SMEs?

Tamás Letoha: What opportunities for SMEs?

Matthias Gottwald: Why are PPPs essential to innovation?

Matthias Gottwald: Why are PPPs essential to innovation?

Peter Sterk: how has IMI impacted medical research?

Peter Sterk: how has IMI impacted medical research?

ADAPTED and the APOE gene

ADAPTED and the APOE gene

PIONEER - What? Who? Why?

PIONEER - What? Who? Why?

What is INNODIA about?

What is INNODIA about?

IMI Stakeholder Forum 2019

IMI Stakeholder Forum 2019

IMI Stakeholder Forum 2019

IMI Stakeholder Forum 2019

IMI Stakeholder Forum 2019

IMI Stakeholder Forum 2019

IMI Stakeholder Forum 2019

IMI Stakeholder Forum 2019

IMI Stakeholder Forum 2019

IMI Stakeholder Forum 2019

IMI Stakeholder Forum 2019

IMI Stakeholder Forum 2019

IMI Stakeholder Forum 2019

IMI Stakeholder Forum 2019

IMI Stakeholder Forum 2019

IMI Stakeholder Forum 2019

IMI Stakeholder Forum 2019

IMI Stakeholder Forum 2019

IMI Stakeholder Forum 2019

IMI Stakeholder Forum 2019

IMI Stakeholder Forum 2019

IMI Stakeholder Forum 2019

IMI Stakeholder Forum 2019

IMI Stakeholder Forum 2019

IMI Stakeholder Forum 2019

IMI Stakeholder Forum 2019

IMI Stakeholder Forum 2019

IMI Stakeholder Forum 2019

Chantal Mathieu: How do patients contribute to the INNODIA project?

Chantal Mathieu: How do patients contribute to the INNODIA project?